Rocket Pharmaceuticals Announces Upcoming Clinical Data Presentations at the 24th Annual Meeting of the American Society of Gene and Cell Therapy streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Image by Pezibear from Pixabay
Going to the movies with your child for the first time is a milestone to be cherished and celebrated. While many movie-loving parents can’t wait to get there with their 2-year-old, it might be wise to grab an aisle seat for an exit strategy if you do go with a child under the age of 3.
I took my twin nieces to a movie theatre for the first time to see
A Bug’s Life when they were only 2. They were wide-eyed with excitement, taking in all the lights and sights and giant candy boxes. Once the movie started, they were enthralled with the animation and giant screen, but it didn’t last; unfortunately, we had to bug out of there mid-movie because it was “too loud.” With hands clasped over their ears, they couldn’t take it anymore, no matter how dazzled they were by the brilliant animation.
Eisai Presents Breadth of Data Across Neurology Portfolio, Including Alzheimer s Disease, Insomnia and Epilepsy
Twenty-one presentations featuring data and information on investigational lecanemab in early Alzheimer s disease, DAYVIGO® (lemborexant) CIV in insomnia, FYCOMPA® (perampanel) CIII in epilepsy and investigational lorcaserin in Dravet Syndrome
News provided by
Share this article
Share this article
WOODCLIFF LAKE, N.J., April 16, 2021 /PRNewswire/ Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced today that data from the company s deep neurology pipeline and portfolio, including Alzheimer s disease, insomnia and epilepsy, will be presented at the 73
rd Annual Meeting of the American Academy of Neurology (AAN), taking place virtually from April 17-22, 2021.
Firmino Filho no combate à pandemia em Teresina meionorte.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from meionorte.com Daily Mail and Mail on Sunday newspapers.
University of Michigan doctor answers parents’ questions about dangerous COVID condition in kids
Without treatment, MIS-C could be life-threatening in children
Meredith Bruckner, Community News Producer, All About Ann Arbor
Published:
Tags:
A girl has her temperature taken. (Pixabay)
ANN ARBOR – Although children are for the most part spared from developing severe illness from COVID-19, as time goes on, states are reporting more cases of a rare condition developing in children called multi-system inflammatory syndrome, or MIS-C.
The condition causes vital organs and tissues to become severely inflamed, and it could be life-threatening without treatment.
The first cases emerged in May 2020 in the United States and Europe. Nearly a year on, 48 states have documented cases of the serious condition.